Exozymes Inc. (EXOZ) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 26, 2026.
- Filings shown
- 11
- Open-market buys
- 5
- Open-market sells
- 1
- Buys, 10b5-1 box not checked
- 5 of 5
Counts cover the 11 most recent Form 4 filings Tradune holds for EXOZ (filed Aug 25 – Oct 26, 2026). SEC EDGAR Form 4 filings for EXOZ last checked Nov 22, 2026, 09:00 UTC; the latest EXOZ filing Tradune holds was filed Oct 26, 2026. This is not guaranteed to be the complete record — see EXOZ's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for EXOZ filed Aug 25 – Oct 26, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
1 open-market sale by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 0 sales· 0 sh
- checkbox disclosed
- On filings with the box not checked
- 1 sale· 3,729 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Michael HeltzenChief Executive Officer | 5 | 0 | 855 | — | +$6,405 |
| Damien Alan PerrimanChief Commercial Officer | 0 | 1 | — | 3,729 | −$19,427 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
39/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at EXOZ
Insiders reported 5 open-market purchases of EXOZ in the trailing 90 days, across 1 distinct buyer. The most recent purchase was reported by Michael Heltzen (Chief Executive Officer) on Aug 26, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 3,729 | $5.21 | 28,692 | −12% | Oct 12, 2026 |
| Option exercise | 3,922 | — | 32,421 | +14% | Oct 9, 2026 |
| Option exercise Restricted Stock Unit | 3,922 | — | — | — | Oct 9, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (right to buy) | 25,000 | — | — | — | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (right to buy) | 10,000 | — | — | — | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (right to buy) | 10,000 | — | — | — | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (right to buy) | 10,000 | — | — | — | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (right to buy) | 10,000 | — | — | — | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (right to buy) | 10,000 | — | — | — | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (right to buy) | 45,000 | — | — | — | Sep 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 4 | $7.58 | 14,708 | +0.0% | Aug 26, 2026 |
| Open-market purchase 10b5-1 box not checked | 250 | $7.60 | 14,453 | +1.8% | Aug 26, 2026 |
| Open-market purchase 10b5-1 box not checked | 251 | $7.35 | 14,704 | +1.7% | Aug 26, 2026 |
| Open-market purchase 10b5-1 box not checked | 100 | $7.50 | 13,953 | +0.7% | Aug 25, 2026 |
| Open-market purchase 10b5-1 box not checked | 250 | $7.52 | 14,203 | +1.8% | Aug 25, 2026 |
| Grant / award | 8,841 | $6.40 | 13,853 | +176% | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Restricted Stock Unit | 19,612 | — | — | — | Aug 19, 2026 |
| Option exercise | 19,612 | — | 28,499 | +221% | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Restricted Stock Unit | 32,964 | — | — | — | Aug 19, 2026 |
| Option exercise | 32,964 | — | 762,837 | +4.5% | Aug 19, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to EXOZ's (Oct 26, 2026).
Frequently asked about EXOZ insider activity
How many insiders bought EXOZ stock in the last 90 days?
1 distinct insider at Exozymes Inc. reported 5 open-market purchases (Form 4 code P) of EXOZ shares in the trailing 90 days, the most recent filed by Michael Heltzen (Chief Executive Officer) on Aug 26, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for EXOZ?
The most recent Form 4 on this page was filed by Damien Alan Perriman (Chief Commercial Officer) on Oct 26, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market EXOZ insider sale shown?
The largest open-market sale among the filings shown was 3,729 EXOZ shares at $5.21 (about $19,427) by Damien Alan Perriman (Chief Commercial Officer) on Oct 12, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent EXOZ insider purchases have the Form 4 10b5-1 box checked?
No. All 5 EXOZ open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Michael Heltzen (Chief Executive Officer) on Aug 26, 2026, 251 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for EXOZ — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.